Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.19.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Schedule of Fair Value Warrants Assumption

The Company calculated the estimated fair value of warrants on the date of issuance and at each subsequent reporting date using the following assumptions:

 

    Six Months Ended  
    June 30, 2019  
Risk-free interest rate     2.09% - 2.46%  
Contractual term (year)     0.37  
Expected volatility     40%
Schedule of Warrants Liabilities Measured at Fair Value Using Significant Unobservable Inputs

The table below provides a reconciliation of the beginning and ending balances for the warrant derivative which is measured at fair value using significant unobservable inputs (Level 3):

 

Balance, December 31, 2018   $ 23,507,247  
Series B Warrants exercised during the three months ended March 31, 2019     (5,635,769 )
Change in the fair value of warrant derivative     (2,597,899 )
Balance, March 31, 2019   $ 15,273,579  

 

Series B Warrants exercised during the three months ended June 30, 2019     (7,733,463 )
Series B Warrants exchanged for Series C Preferred Stock     (3,671,024 )
Change in the fair value of warrant derivative     (2,111,684 )
Balance, June 30, 2019   $ 1,757,408  
Schedule of Earning Per Share

Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.

  

    Three Months Ended June 30,     Six Months Ended June 30,  
    2019     2018     2019     2018  
Numerator for diluted loss per share:                                
Net loss attributable to common stockholders   $ 7,422     $ (2,716,255 )   $ (1,629,555 )   $ (4,128,941 )
Less: Change in fair value of Series B warrant derivative     -     -       (4,709,583 )     -  
Numerator for diluted loss per share   $ 7,422   $ (2,716,255 )   $ (6,339,138 )   $ (4,128,941 )
                                 
Denominator for diluted loss per share:                                
Weighted average common shares     19,042,699       3,679,500       15,388,342       3,679,500  
Warrants     -       -       127,839       -  
Denominator for diluted loss per share     19,042,699       3,679,500       15,516,181       3,679,500  

Schedule of Potential Dilutive Securities

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

 

    Three Months Ended June 30,     Six Months Ended June 30,  
    2019     2018     2019     2018  
Preferred shares     3,752,000       378,260       1,886,000       322,428  
Warrants     5,526,841       364,859       3,299,569       364,859  
Options     1,063,419       125,000       1,063,419       125,000  
Total anti-dilutive weighted average shares     10,342,260       868,119       6,248,988       812,287